ET receptor antagonist 3 (compound 17d) is an orally active ET receptor antagonist with an IC50 of 0.26 nM, utilized for pulmonary arterial hypertension (PAH) research. This compound demonstrates efficacy in mitigating monocrotaline-induced PAH in a rat
Molecular Weight:
548.61
Formula:
C27H28N6O5S
* VAT and and shipping costs not included. Errors and price changes excepted